Total Payments
$12,240
2024 Payments
$1,550
Companies
32
Transactions
630
Medicare Patients
6,288
Medicare Billing
$454,127
Payment Breakdown by Category
Food & Beverage$12,151 (99.3%)
Research$76.42 (0.6%)
Education$12.51 (0.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,151 | 628 | 99.3% |
| Unspecified | $76.42 | 1 | 0.6% |
| Education | $12.51 | 1 | 0.1% |
Payments by Type
General
$12,163
629 transactions
Research
$76.42
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $2,226 | 132 | $0 (2024) |
| ABBVIE INC. | $1,759 | 89 | $0 (2024) |
| Amgen Inc. | $1,435 | 71 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,310 | 64 | $0 (2024) |
| UCB, Inc. | $788.06 | 34 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $715.33 | 30 | $0 (2024) |
| GENZYME CORPORATION | $692.65 | 30 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $654.58 | 30 | $0 (2024) |
| Lilly USA, LLC | $598.63 | 33 | $0 (2024) |
| PFIZER INC. | $474.25 | 26 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,550 | 68 | Amgen Inc. ($293.65) |
| 2023 | $2,026 | 97 | Janssen Biotech, Inc. ($436.36) |
| 2022 | $2,093 | 112 | Janssen Biotech, Inc. ($846.35) |
| 2021 | $1,388 | 79 | AbbVie Inc. ($393.66) |
| 2020 | $1,146 | 63 | AbbVie Inc. ($152.20) |
| 2019 | $1,771 | 87 | AbbVie, Inc. ($302.82) |
| 2018 | $1,214 | 66 | Amgen Inc. ($224.91) |
| 2017 | $1,051 | 58 | Amgen Inc. ($260.97) |
All Payment Transactions
630 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $9.45 | General |
| Category: Dermatology | ||||||
| 12/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $26.67 | General |
| Category: Immunology | ||||||
| 12/11/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: DERMATOLOGY | ||||||
| 12/10/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $24.68 | General |
| Category: DERMATOLOGY | ||||||
| 12/03/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $27.94 | General |
| Category: Inflammation | ||||||
| 12/03/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $25.15 | General |
| Category: Immunology | ||||||
| 11/14/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $7.39 | General |
| Category: Inflammation | ||||||
| 11/11/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $27.87 | General |
| Category: DERMATOLOGY | ||||||
| 11/04/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $32.09 | General |
| Category: DERMATOLOGY | ||||||
| 10/29/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: Immunology | ||||||
| 10/28/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $26.34 | General |
| Category: Dermatology | ||||||
| 10/23/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: Immunology | ||||||
| 10/07/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $33.27 | General |
| Category: Dermatology | ||||||
| 10/01/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $29.07 | General |
| Category: Inflammation | ||||||
| 09/30/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $11.74 | General |
| Category: IMMUNOLOGY | ||||||
| 09/25/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $32.46 | General |
| Category: Immunology | ||||||
| 09/18/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: Immunology | ||||||
| 09/16/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $23.26 | General |
| Category: Dermatology | ||||||
| 09/10/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $25.52 | General |
| Category: Inflammation | ||||||
| 09/04/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $28.02 | General |
| Category: Immunology | ||||||
| 08/29/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.72 | General |
| Category: IMMUNOLOGY | ||||||
| 08/26/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/21/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: DERMATOLOGY | ||||||
| 08/20/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $31.17 | General |
| Category: Inflammation | ||||||
| 08/06/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: Immunology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| BOTOX (onabotulinumtoxinA) for the Reduction of Masseter Muscle Prominence: A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study | ABBVIE INC. | $76.42 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,496 | 2,753 | $261,690 | $108,933 |
| 2022 | 19 | 1,676 | 3,001 | $284,843 | $120,801 |
| 2021 | 22 | 1,657 | 2,965 | $270,597 | $118,920 |
| 2020 | 21 | 1,459 | 2,635 | $260,735 | $105,473 |
Total Patients
6,288
Total Services
11,354
Medicare Billing
$454,127
Procedure Codes
82
All Medicare Procedures & Services
82 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 201 | 253 | $42,650 | $21,212 | 49.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 261 | 359 | $23,920 | $13,717 | 57.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 94 | 142 | $20,420 | $12,799 | 62.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 218 | 300 | $38,065 | $10,900 | 28.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 148 | 172 | $28,100 | $10,399 | 37.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 144 | 174 | $17,780 | $10,384 | 58.4% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 32 | 34 | $15,910 | $7,998 | 50.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 154 | 877 | $28,588 | $4,708 | 16.5% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 25 | 30 | $11,000 | $3,070 | 27.9% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 34 | 57 | $4,107 | $2,328 | 56.7% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 13 | 15 | $5,970 | $1,990 | 33.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $2,400 | $1,492 | 62.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 19 | 19 | $3,150 | $1,464 | 46.5% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 31 | 31 | $3,200 | $1,344 | 42.0% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 13 | 14 | $3,770 | $1,330 | 35.3% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 23 | 37 | $3,280 | $1,311 | 40.0% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 14 | 14 | $2,750 | $1,252 | 45.5% |
| 69100 | Biopsy of ear | Office | 2023 | 15 | 16 | $3,225 | $829.87 | 25.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 14 | 24 | $1,515 | $264.18 | 17.4% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 32 | 174 | $1,890 | $138.54 | 7.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 217 | 271 | $46,070 | $22,438 | 48.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 197 | 235 | $38,775 | $14,943 | 38.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 187 | 220 | $20,945 | $14,311 | 68.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 252 | 325 | $19,500 | $12,608 | 64.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 110 | 148 | $20,720 | $12,453 | 60.1% |
About Dr. David Bushore, M.D
Dr. David Bushore, M.D is a Dermatology healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/18/2005. The National Provider Identifier (NPI) number assigned to this provider is 1568461036.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Bushore, M.D has received a total of $12,240 in payments from pharmaceutical and medical device companies, with $1,550 received in 2024. These payments were reported across 630 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($12,151).
As a Medicare-enrolled provider, Bushore has provided services to 6,288 Medicare beneficiaries, totaling 11,354 services with total Medicare billing of $454,127. Data is available for 4 years (2020–2023), covering 82 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Austin, TX
- Active Since 07/18/2005
- Last Updated 09/24/2012
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1568461036
Products in Payments
- TREMFYA (Drug) $1,443
- COSENTYX (Biological) $842.73
- Enbrel (Biological) $840.85
- SKYRIZI (Biological) $793.82
- DUPIXENT (Biological) $681.70
- Cimzia (Drug) $662.49
- REMICADE (Biological) $630.03
- TALTZ (Drug) $598.63
- Otezla (Drug) $593.84
- EUCRISA (Drug) $474.25
- Humira (Biological) $456.12
- COSENTYX (Drug) $409.97
- ILUMYA (Biological) $328.07
- Winlevi (Drug) $287.52
- RINVOQ (Biological) $234.88
- HUMIRA (Biological) $171.84
- DUPIXENT DUPILUMAB INJECTION (Biological) $155.15
- STELARA (Biological) $153.28
- DUOBRII (Drug) $149.28
- DORYX (Drug) $144.56
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Austin
Dr. Edward Lain, M.d, M.D
Dermatology — Payments: $2.3M
Dermatology $2.3M
Daniel Carrasco, Md, MD
Dermatology — Payments: $1.2M
Dermatology $1.2M
Dale Schaefer, Md, MD
Dermatology — Payments: $1.2M
Dermatology $1.2M
Janet Dubois, M.d, M.D
Dermatology — Payments: $1.1M
Dermatology $1.1M
Ms. Heidi Prather, M.d, M.D
Dermatology — Payments: $530,857
Dermatology $530,857
Daniel Friedmann, M.d, M.D
Dermatology — Payments: $231,608
Dermatology $231,608